NEULAND LAB LTD. Valuation
NEULANDLAB · Healthcare · Current price ₹22,995
Is NEULAND LAB LTD. undervalued?
DocStoX estimates the fair value of NEULAND LAB LTD. at ₹8,087 per share, versus the current market price of ₹22,995. That puts the stock about -64.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹1,662), Relative P/E (₹11,096), Graham floor (₹3,054), Analyst target (₹24,335). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1,662 (bear) to ₹8,087 (base) to ₹24,335 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
NEULAND LAB LTD. trades at a P/E of 81.0x and a P/B of 13.1x, with a dividend yield of 0.1%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on NEULAND LAB LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.